Global Endowment Management »

Aeglea Biotherapeutics shares owned by Global Endowment Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Global Endowment Management from 13F filings

Historical chart of Global Endowment Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Global Endowment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Global Endowment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $11M 513k 21.52

More positions owned by Global Endowment Management

Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Betbuld Msci (BBRE)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Txo Partners Com Unit (TXO)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Apple (AAPL)
Ishares Msci Jpn Etf New (EWJ)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Vanguard Index Fds Real Estate Etf (VNQ)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Spyre Therapeutics Com New (SYRE)
Ishares Tr 3 7 Yr Treas Bd (IEI)

View all positions for Global Endowment Management

Top funds holding Aeglea Biotherapeutics

Perceptive Advisors
VR Adviser
Commodore Capital
venBio Select Advisor
Cormorant Asset Management
EcoR1 Capital
Franklin Resources
BVF
Wellington Management Company
Citadel Advisors
Braidwell
Global Endowment Management
Fairmount Funds Management
Boxer Capital
Logos Global Management

View all funds holding Aeglea Biotherapeutics